| Functional impact of global rare copy number variation in autism spectrum disorders D Pinto, AT Pagnamenta, L Klei, R Anney, D Merico, R Regan, J Conroy, ... Nature 466 (7304), 368, 2010 | 2319 | 2010 |
| A genome-wide scan for common alleles affecting risk for autism R Anney, L Klei, D Pinto, R Regan, J Conroy, TR Magalhaes, C Correia, ... Human molecular genetics 19 (20), 4072-4082, 2010 | 720 | 2010 |
| The multiplex model of the genetics of Alzheimer’s disease R Sims, M Hill, J Williams Nature Neuroscience, 1-12, 2020 | 358 | 2020 |
| The 5-HT2C receptor and antipsychoticinduced weight gain–mechanisms and genetics GP Reynolds, MJ Hill, SL Kirk Journal of Psychopharmacology 20 (4_suppl), 15-18, 2006 | 194 | 2006 |
| SB‐656104‐A, a novel selective 5‐HT7 receptor antagonist, modulates REM sleep in rats DR Thomas, S Melotto, M Massagrande, AD Gribble, P Jeffrey, ... British journal of pharmacology 139 (4), 705-714, 2003 | 171 | 2003 |
| Expression quantitative trait loci in the developing human brain and their enrichment in neuropsychiatric disorders HE O’Brien, E Hannon, MJ Hill, CC Toste, MJ Robertson, JE Morgan, ... Genome Biology 19 (1), 194, 2018 | 157 | 2018 |
| The emerging roles of TCF4 in disease and development MP Forrest, MJ Hill, AJ Quantock, E Martin-Rendon, DJ Blake Trends in molecular medicine 20 (6), 322-331, 2014 | 157 | 2014 |
| Development of strategies for SNP detection in RNA-seq data: application to lymphoblastoid cell lines and evaluation using 1000 Genomes data EM Quinn, P Cormican, EM Kenny, M Hill, R Anney, M Gill, AP Corvin, ... PloS one 8 (3), e58815, 2013 | 150 | 2013 |
| Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone ZA Hughes, KR Starr, CJ Langmead, M Hill, GD Bartoszyk, JJ Hagan, ... European journal of pharmacology 510 (1-2), 49-57, 2005 | 150 | 2005 |
| Oxytocin receptor (OXTR) does not play a major role in the aetiology of autism: genetic and molecular studies KE Tansey, KJ Brookes, MJ Hill, LE Cochrane, M Gill, D Skuse, C Correia, ... Neuroscience letters 474 (3), 163-167, 2010 | 131 | 2010 |
| Knockdown of the psychosis susceptibility gene ZNF804A alters expression of genes involved in cell adhesion MJ Hill, AR Jeffries, RJB Dobson, J Price, NJ Bray Human molecular genetics 21 (5), 1018-1024, 2011 | 112 | 2011 |
| Functionality of promoter microsatellites of arginine vasopressin receptor 1A (AVPR1A): implications for autism KE Tansey, MJ Hill, LE Cochrane, M Gill, RJL Anney, L Gallagher Molecular autism 2 (1), 3, 2011 | 100 | 2011 |
| Genetic risk for Alzheimer’s disease is concentrated in specific macrophage and microglial transcriptional networks KE Tansey, D Cameron, MJ Hill Genome medicine 10 (1), 14, 2018 | 99 | 2018 |
| The Psychiatric Risk Gene Transcription Factor 4 (TCF4) Regulates Neurodevelopmental Pathways Associated With Schizophrenia, Autism, and Intellectual … MP Forrest, MJ Hill, DH Kavanagh, KE Tansey, AJ Waite, DJ Blake Schizophrenia bulletin 44 (5), 1100-1110, 2017 | 94 | 2017 |
| Psychosis risk candidate ZNF804A localizes to synapses and regulates neurite formation and dendritic spine structure PJM Deans, P Raval, KJ Sellers, NJF Gatford, S Halai, RRR Duarte, ... Biological psychiatry 82 (1), 49-61, 2017 | 94 | 2017 |
| Evidence That Schizophrenia Risk Variation in the ZNF804A Gene Exerts Its Effects During Fetal Brain Development MJ Hill, NJ Bray American Journal of Psychiatry 169 (12), 1301-1308, 2012 | 92 | 2012 |
| Transcriptional consequences of schizophrenia candidate miR-137 manipulation in human neural progenitor cells MJ Hill, JG Donocik, RA Nuamah, CA Mein, R Sainz-Fuertes, NJ Bray Schizophrenia research 153 (1), 225-230, 2014 | 81 | 2014 |
| 5-HT2C receptor gene polymorphisms associated with antipsychotic drug action alter promoter activity MJ Hill, GP Reynolds Brain research 1149, 14-17, 2007 | 58 | 2007 |
| Allelic differences in nuclear protein binding at a genome-wide significant risk variant for schizophrenia in ZNF804A MJ Hill, NJ Bray Molecular psychiatry 16 (8), 787, 2011 | 46 | 2011 |
| MiR-137-derived polygenic risk: effects on cognitive performance in patients with schizophrenia and controls D Cosgrove, D Harold, O Mothersill, R Anney, MJ Hill, NJ Bray, ... Translational psychiatry 7 (1), e1012, 2017 | 45 | 2017 |
